Nevo syndrome
A rare genetic disorder
Overview[edit | edit source]
Nevo syndrome is a rare genetic disorder characterized by overgrowth, developmental delay, and distinctive facial features. It is inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are required for an individual to be affected by the disorder.
Genetics[edit | edit source]
Nevo syndrome is caused by mutations in a specific gene, although the exact gene responsible has not been definitively identified. The disorder follows an autosomal recessive inheritance pattern, which is depicted in the diagram to the right. In this pattern, both parents of an affected individual are typically carriers of one copy of the mutated gene but do not show symptoms of the disorder themselves.
Clinical Features[edit | edit source]
Individuals with Nevo syndrome often present with a range of clinical features, including:
- Overgrowth: Excessive growth in height and weight during infancy and early childhood.
- Developmental delay: Delays in reaching developmental milestones such as sitting, walking, and talking.
- Distinctive facial features: These may include a prominent forehead, wide-set eyes, and a broad nasal bridge.
- Hypotonia: Reduced muscle tone, which can affect movement and posture.
Diagnosis[edit | edit source]
The diagnosis of Nevo syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing may be used to confirm the diagnosis by identifying mutations in the gene associated with the disorder.
Management[edit | edit source]
There is currently no cure for Nevo syndrome, and treatment is focused on managing symptoms and supporting development. This may include:
- Physical therapy to improve muscle tone and coordination.
- Speech therapy to assist with communication skills.
- Occupational therapy to help with daily living activities.
Prognosis[edit | edit source]
The prognosis for individuals with Nevo syndrome varies depending on the severity of symptoms and the presence of any associated complications. Early intervention and supportive therapies can improve quality of life and developmental outcomes.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD